PMID: 8462339Apr 1, 1993Paper

The molecular biology of lung cancer pathogenesis

Chest
J D Minna

Abstract

Lung cancers exhibit multiple genetic lesions including mutations activating the dominant cellular proto-oncogenes as well as those inactivating the recessive or "tumor suppressor" genes. Candidate tumor suppressor genes include those on chromosomes 1p, 1q, 3p14, 3p21.3, 3p25 (VHL gene), 5q21 (APC/MCC gene cluster), 9p21-22 (interferon gene cluster), 11p, 13q (rb gene), 16p24, and 17p (p53 gene). Mutations in p53 inactivate its transcriptional activity, while replacement of a wild-type p53 in lung cancer cells inhibits growth and tumorigenicity suggesting that p53 acts as a master growth regulatory switch. Lung cancer cells exhibit several positive autocrine growth factor loops and express nicotine receptors which could function as tumor promoting systems. In addition, they express a negative autocrine loop involving opioids and their receptors which is reversed by nicotine acting through nicotinic acetylcholine receptors. The presence of nicotine receptors suggests nicotine or its metabolites may play a direct role in lung cancer pathogenesis.

References

Aug 21, 1992·Cell·B Vogelstein, K W Kinzler
Jan 1, 1992·Molecular Biology of the Cell·S K GuptaG L Johnson
Jun 1, 1992·Trends in Pharmacological Sciences·W BurschR Schulte-Hermann
Jun 28, 1991·Cell·G T Williams
May 1, 1991·Genes, Chromosomes & Cancer·J Whang-PengJ D Minna
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R Maneckjee, J D Minna
Jul 1, 1990·The Journal of Clinical Investigation·T TakahashiJ D Minna
Jul 1, 1990·Genes, Chromosomes & Cancer·R LukeisS Hasthorpe
Apr 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J M HorowitzR A Weinberg
Aug 30, 1990·The New England Journal of Medicine·R J SlebosW J Mooi
Aug 1, 1990·Journal of the National Cancer Institute·N E CaporasoS Aisner
Aug 1, 1990·Journal of the National Cancer Institute·T A SellersH Rothschild
Oct 27, 1989·Science·T TakahashiJ D Minna
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A WestonB F Trump
Jun 1, 1982·Cancer Genetics and Cytogenetics·J Whang-PengJ D Minna
Jul 1, 1993·American Journal of Respiratory Cell and Molecular Biology·J L BroersR I Linnoila

❮ Previous
Next ❯

Citations

Aug 9, 2001·International Journal of Cancer. Journal International Du Cancer·S RorkeS C Tang
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·I TakanamiA Raz
Sep 10, 2003·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Iwao Takanami, Ken Takeuchi
Aug 7, 1999·Clinical Reviews in Allergy & Immunology·M C Seeds, D A Bass
Dec 12, 2012·Cancer Metastasis Reviews·Michael S YouYian Wang
Aug 13, 2005·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·Atsushi MorioHiroshi Izumi
Nov 1, 1996·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·A F ChambersA G Casson
Aug 1, 1994·British Journal of Cancer·C WalkerG R Dixon
Jan 1, 1996·Critical Reviews in Oncology/hematology·C A KristensenH H Hansen
Aug 1, 1997·The Annals of Thoracic Surgery·A OhgamiK Yasumoto
Dec 1, 1996·Cancer Genetics and Cytogenetics·Y OhnukiC C Harris
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y SekidoJ D Minna
Jan 26, 2013·Carcinogenesis·Ariela L Marshall, David C Christiani
Dec 31, 1997·Journal of the National Cancer Institute·P M CinciripiniB S Kramer
May 17, 2007·Current Opinion in Pediatrics·Gary A Visner, Samuel B Goldfarb
Feb 26, 1998·American Journal of Respiratory Cell and Molecular Biology·V GouyerE Brambilla
Jul 29, 1999·American Journal of Respiratory Cell and Molecular Biology·K WakamatsuN Hara
Oct 1, 1995·The Journal of Pathology·S X JiangT Kameya
Jun 9, 1998·Annals of the New York Academy of Sciences·S S Hecht
Jan 1, 1996·Progress in Histochemistry and Cytochemistry·J C Alers, H van Dekken
Dec 16, 2005·Neoplasia : an International Journal for Oncology Research·Ying YanMing You
Mar 15, 2006·Neoplasia : an International Journal for Oncology Research·Ying YanMing You
Dec 10, 2008·Pharmacology & Therapeutics·Richard D EgletonPiyali Dasgupta
Aug 3, 2004·Journal of Clinical Pharmacology·XingXiang WangYunPeng Shang
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Piyali DasguptaSrikumar Chellappan
Jul 1, 1997·Cancer Treatment Reviews·P VermylenJ P Sculier
Jan 15, 1999·Hematology/oncology Clinics of North America·M You, G Bergman
Sep 1, 1994·The Annals of Thoracic Surgery·J M SiegfriedR J Landreneau
Jan 1, 1996·Neuron·R Hen
Sep 17, 1998·Japanese Journal of Cancer Research : Gann·H FujimotoM Ando
Feb 27, 2001·Japanese Journal of Cancer Research : Gann·N Shindo-OkadaY Nagamachi
Jan 23, 2002·Japanese Journal of Cancer Research : Gann·Nobuko Shindo-OkadaYasuhiro Nagamachi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.